Increased telomerase activity and absence of p53 mutation in oligo-astrocytomas induced by N-ethyl-N-nitrosourea in rats

Cancer Letters

Volumn 126, Issue 2, 1998, Pages 157-164

  Sakitani, Hiroyuki ^a   Tsujiuchi, Toshifumi ^a   Kobitsu, Kunihiko ^a   Kido, Akira ^a   Iki, Katsumichi ^a   Takahama, Makoto ^a   Nakamura, Mitsuhiro ^a   Sakaki, Toshisuke ^a   Nakae, Dai ^a   Konishi, Yoichi ^a   Tsutsumi, Masahiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brain tumor; p53; Rat; Telomerase

Indexed keywords

ETHYLNITROSOUREA; PROTEIN P53; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

ANIMALS; ASTROCYTOMA; BRAIN NEOPLASMS; CARCINOGENS; ETHYLNITROSOUREA; FEMALE; GENES, P53; MALE; NEOPLASM PROTEINS; RATS; RATS, INBRED F344; TELOMERASE;

ANIMALIA;

EID: 0031896297     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00549-1     Document Type: Article

References (51)

1. Druckrey H., Ivankovic S., Preussmann R. Teratogenic and carcinogenic effects in the offspring after a single injection of ethylnitrosourea to pregnant rats. Nature. 210:1966;1378-1379.
2. Koesther A., Swenberg J.A., Wechsler W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am. J. Pathol. 63:1971;37-50.
3. Mauro A., Giordana M., Migheil A. Glial fibrillary acidic protein (GFAP) in rat brain tumors transplacentally induced by ethylnitrosourea. J. Neurol. Sci. 61:1983;349-355.
4. Lantos P.L., Pilkington G.J. The development of experimental brain tumors: a sequential light and electron microscope study of the subependimal plate. Acta Neuropathol. 45:1979;167-175.
5. Valerij A.A., Vladimir G.B., Algerd S.P., Domitrij N.T., Margeris Y.L. Study of post-natal effect of chemopreventive agents on ethylnitrosourea-induced transplacental carcinogenesis in rats. III. Inhibitory action of indomethacin, voltaren, theophylline and ε-aminocaproic acid. Carcinogenesis. 17:1996;1935-1939.
6. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 43:1985;405-413.
7. Greider C.W., Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell. 51:1987;8887-8898.
8. Blackburn E.H. Structure and function of telomeres. Nature. 350:1991;569-573.
9. Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J. Theor. Biol. 41:1973;181-190.
10. Avilion A.A., Piatyszek M.A., Gupta J., Shay J.W., Bacchetti S., Greider C.W. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res. 56:1996;645-650.
11. Nilsson P., Mehle C., Remes K., Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene. 9:1994;3043-3048.
12. Counter C.M., Hirte H.W., Bacchetti S., Harley C.B. Telomerase activity in human ovarian carcinoma. Proc. Natl. Acad. Sci. USA. 91:1994;2900-2904.
13. Chadeneau C., Hay K., Hirite H.W., Gallinger S., Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55:1995;2533-2536.
14. Langford L.A., Piatyszek M.A., Xu R., Scholid S.C. Jr., Shay J.W. Telomerase activity in human brain tumors. Lancet. 346:1995;1267-1268.
15. Broccoli D., Young W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA. 92:1995;9082-9086.
16. Hiyama K., Hirai Y., Koizumi S., Akiyama M., Hiyama E., Piatyszek M.A., Shay J.W., Ishioka S., Yamakido M. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J. Immunol. 155:1995;3711-3715.
17. Counter C.M., Gupta J., Harley C.B., Leber B., Bacchetti S. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood. 85:1995;2315-2320.
18. Harle-Bachor C., Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA. 93:1996;6476-6481.
19. Yasumoto S., Kunimura C., Kikuchi K., Tahara H., Ohji H., Yamamoto H., Ide T., Utakoji T. Telomerase activity in normal human epithelial cells. Oncogene. 13:1996;433-439.
20. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science. 266:1994;2011-2015.
21. Bednarek A., Budunova I., Slaga T.J., Aldaz C.M. Increased telomerase activity in mouse skin premalignant progression. Cancer Res. 55:1955;4566-4569.
22. Tsujiuchi T., Tsutsumi M., Kido A., Kobitsu K., Takahama M., Majima T., Denda A., Nakae D., Konishi Y. Increased telomerase activity in hyperplastic nodules and hepatocellular carcinomas induced by a choline deficient L-amino acid defined diet in rats. Jpn. J. Cancer Res. 87:1996;1111-1115.
23. Kobitsu K., Tsutsumi M., Tsujiuchi T., Suzuki F., Kido A., Okajima E., Fukuda T., Sakaki T., Konishi Y. Shortened telomerase length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines. Mol. Carcinogen. 18:1997;153-159.
24. Kido A., Tsujiuchi T., Tsutsumi M., Takahama M., Miyauchi Y., Mii Y., Tamai S., Konishi Y. Increased telomerase activity is not directly related to metastatic potential in rat transplantable osteosarcomas. Cancer Lett. 117:1997;67-71.
25. Yoshimi N., Ino N., Suzuki M., Hara A., Nakatani K., Sato S., Mori H. Telomerase activity of normal tissues and neoplasms in rat colon carcinogenesis induced by methylazoxymethanol acetate and its difference from that of human colonic tissues. Mol. Carcinogen. 16:1996;1-5.
26. Marshal C.J. Tumor suppressor genes. Cell. 64:1991;313-326.
27. Vogelstein B., Kinzler K.W. p53 function and dysfunction. Cell. 70:1992;523-526.
28. Nigro J.M., Baker S.J., Preisinger A.C., Jessup J.M., Hostetter R., Cleary K., Bibner S.H., Davidson N., Baylin S., Devilee P., Glover T., Collins F.S., Weston A., Modali R., Harris C.C., Vogelstein B. Mutation in the p53 gene occurs in diverse human tumor types. Nature. 342:1992;705-708.
29. Hollstein M., Sidransky D., Vogelstein B., Harris C.C. P53 mutation in human cancer. Science. 253:1991;49-53.
30. Greenblatt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 15:1994;4855-4878.
31. Louis D.N. The p53 gene and protein in human brain tumors. Neuropathol. Exp. Neurol. 53:1994;11-21.
32. Tada M., Iggo R.D., Nozaki M., Matsumoto R., Sawamura Y., Shinohe Y., Ikeda J., Abe H. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses. Mol. Carcinogen. 18:1997;171-176.
33. Hayashi Y., Yamashita J., Yamaguchi K. Timing and role of p53 mutation in the recurrence of glioma. Biochem. Biophys. Res. Commun. 180:1991;1145-1150.
34. Sidransky D., Mikkeisen T., Schwechheimer K., Rosenblum M.L., Cavanee W., Vogelstein B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature. 355:1992;846-847.
35. Wynford-Thomas D., Bond J.A., Wyllie F.S., Jones C.J. Does telomere shortening drive selection for p53 mutation in human cancer. Mol. Carcinogen. 12:1995;119-123.
36. Pandita T.K., Benvenuto J.A., Shay J.W., Pandita R.K., Rakovitch E., Geard C.R., Antman K.H., Newman R.A. Effect of penclomedine on telomere fusions, chromatin bledding, and cell viability with and without telomerase activity and abrogated p53 function. Biochem. Pharmacol. 53:1977;409-415.
37. W. Janisch, Tumor of the central nervous system, in: V. Turusov, U. Mohr (Eds.), Pathology of Tumors in Laboratory Animals, IARC Scientific, Lyon, 1990, pp. 677-689.
38. Wright W.E., Shay J.W., Piatyszek M.A. Modification of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res. 23:1995;3794-3795.
39. Church C.M., Gilbert W. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1984;1991-1995.
40. Makino H., Ishizaka Y., Tsujimoto A., Nakamura T., Onda M., Sugimura T., Nagao M. Rat p53 gene mutation in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc. Natl. Acad. Sci. USA. 89:1992;4850-4854.
41. Lantos P.L., Pilkington G.J. The development of experimental brain tumors: a sequential light and electron microscope study of the subependymal plate. Acta Neuropathol. 45:1979;167-175.
42. deLange T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA. 91:1994;2882-2885.
43. Hiyama K., Hiyama E., Ishida S., Yamakido M., Inai K., Gazdar A.F., Piatyszek M.A., Shay J.W. Telomerase activity in small-cell and non small-cell lung cancers. J. Natl. Cancer Inst. 87:1995;895-902.
44. Chadeneau C., Hay K., Hirte H.W., Gallinger S., Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 83:1995;2533-2536.
45. Apiwat M., Pakpoom S., Saengsoon T., Virote S., Anavaj S., Saowanee Y., Narin V. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res. 5:1996;3530-3533.
46. Muller W., Afra D., Schroder R. Supratentorial recurrence of gliomas: morphological studies in relation to time intervals with astrocytomas. Acta Neurochir. 37:1977;75-91.
47. Hiraga S., Arita N., Ohnish T., Izumoto S., Taki T., Yamamoto H., Higuchi M., Hayakawa T. Transformation of type 1 astrocytes with N-ethyl-N-nitrosourea: establishment of an in vitro system and the role of the p53 gene. Glia. 13:1995;51-63.
48. Chozick B.S., Weicker M.E., Pezzullo J.C.et al. Pattern of mutant p53 expression in human astrocytomas suggests the existence of alternative pathways of tumorigenesis. Cancer. 73:1994;406-415.
49. Shay J.W., Wright W.E., Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochem. Biophys. Acta. 1072:1991;1-7.
50. Waf1/Cip1 gene into a carcinoma cell line of the uterine cervix with inactivated p53. Cancer Lett. 116:1997;233-239.
51. Parkinson E.K., Newbold R.F., Keith W.N. The genetic basis of human keratinocyte immortalization in squamous cell carcinoma development: the role of telomerase reactivation. Eur. J. Cancer. 33:1997;727-734.